Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate UpdatesGlobeNewsWire • 11/07/19
Corbus Pharmaceuticals Holdings Inc (CRBP) COO Robert Paul Discordia Bought $87,900 of SharesGuruFocus • 08/12/19
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
Corbus Pharmaceuticals (CRBP) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/08/19
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
Corbus Pharmaceuticals (CRBP) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 05/02/19
All You Need to Know About Corbus Pharmaceuticals Rating Upgrade to BuyZacks Investment Research • 04/15/19
Corbus Pharmaceuticals (CRBP) Stock Moves -1.23%: What You Should KnowZacks Investment Research • 04/02/19
Corbus Pharmaceuticals (CRBP) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 03/26/19
Corbus Pharmaceuticals Holdings Inc (CRBP) Q4 2018 Earnings Conference Call TranscriptThe Motley Fool • 03/12/19
Corbus Pharmaceuticals (CRBP) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/12/19